Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc., as indicated in the metadata) on November 6, 2008. The report serves to announce the financial results for the fiscal quarter ended September 30, 2008, pursuant to Item 2.02 (Results of Operations and Financial Condition).
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the source text.
Material Changes
The filing does not provide specific data regarding material changes versus the prior comparable period. It solely references the issuance of a press release containing the quarterly results.
Guidance, Outlook, and Risks
The provided text does not include management commentary, forward-looking guidance, specific risk factors, contingencies, or unusual items. The document acts as a notification that such information is available in the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Verify the correct registrant name is Oculus Innovative Sciences, Inc., noting the discrepancy with the metadata label "Sonoma Pharmaceuticals, Inc."
- Retrieve and review Exhibit 99.1 (the November 6, 2008 press release) to obtain actual financial figures for the quarter ended September 30, 2008.
- Confirm the specific revenue and net income figures reported in the press release to assess performance trends.
- Check for any forward-looking statements or risk disclosures within the full press release text.